Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Xenon Pharmaceuticals Inc. XENE

Set alert

Price alert · XENE

All alert types
38.36 USD +0.74 +1.97%

As of Nov 3, 12:39 PM ET

Bid
38.35 × 2
Ask
38.39 × 2
37.78 Day range 38.99
33.49 52-week range 70.96
YTD
-14.41%
1 year
-6.71%
Open
38.04
Prev close
37.62
Mkt cap
3.71B
Vol
330.85K
Avg vol
1.54M
EPS
-4.74
P/E
0.00
Div yield
0.00%
More statistics
Low
37.78
High
38.99
Forward P/E
-8.00
Beta
0.08
Short ratio
2.61
Inst. own
110.45%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
45.35
200-d avg
52.37
1y target
71.75

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for XENE has not been loaded yet. Try again in a moment.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 71.75 +87.0% upside
Target (low)
46.00
Target (mean)
71.75
Target (high)
90.00
Ratings (0m) 18 17 buy · 1 hold · 0 sell
  • Strong buy3
  • Buy14
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 18
  • 1 month ago 19
  • 2 months ago 20

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

XENE analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.14-1.29 – -0.94-1.15+0.5%00.0%11
Next quarter-1.16-1.35 – -0.85-1.31+11.3%840.93K0.0%11
Current year-4.63-4.93 – -4.06-4.36-6.1%1.26M-83.2%13
Next year-4.70-5.50 – -1.90-4.63-1.6%26.97M+2045.7%13

Upgrades and downgrades

The latest rating changes

XENE analyst upgrades and downgrades
DateFirmActionFromTo
Sep 18, 2026RBC CapitalMaintainedOutperformOutperform
Sep 18, 2026WedbushMaintainedOutperformOutperform
Sep 18, 2026Wells FargoMaintainedOverweightOverweight
Sep 18, 2026Deutsche BankDowngradeBuyHold
Sep 18, 2026NeedhamMaintainedBuyBuy
Sep 18, 2026BairdMaintainedOutperformOutperform
Aug 7, 2026RBC CapitalMaintainedOutperformOutperform
May 27, 2026JP MorganMaintainedOverweightOverweight
May 12, 2026JP MorganMaintainedOverweightOverweight
May 8, 2026RBC CapitalMaintainedOutperformOutperform
May 8, 2026NeedhamMaintainedBuyBuy
Mar 16, 2026WedbushMaintainedOutperformOutperform
Mar 10, 2026Wells FargoMaintainedOverweightOverweight
Mar 10, 2026WedbushMaintainedOutperformOutperform
Mar 10, 2026Deutsche BankMaintainedBuyBuy
Mar 10, 2026HC Wainwright & Co.MaintainedBuyBuy
Mar 9, 2026NeedhamMaintainedBuyBuy
Mar 9, 2026BairdMaintainedOutperformOutperform
Feb 27, 2026NeedhamMaintainedBuyBuy
Feb 27, 2026Wells FargoMaintainedOverweightOverweight
Feb 24, 2026Wolfe ResearchInitiated—Outperform
Jan 9, 2026JP MorganMaintainedOverweightOverweight
Dec 11, 2025Wells FargoMaintainedOverweightOverweight
Nov 18, 2025JP MorganMaintainedOverweightOverweight
Nov 4, 2025RBC CapitalMaintainedOutperformOutperform
Nov 4, 2025Wells FargoMaintainedOverweightOverweight
Nov 4, 2025NeedhamReiteratedBuyBuy
Oct 7, 2025Chardan CapitalMaintainedBuyBuy
Sep 2, 2025RBC CapitalReiteratedOutperformOutperform
Aug 12, 2025Chardan CapitalMaintainedBuyBuy